Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q4 2020 | 2021-03-17 | Future report Set alerts | |
Q3 2020 | 2020-11-12 | 0.00 | 0.00 |
Q2 2020 | 2020-08-14 | -0.60 | -0.60 |
Q1 2020 | 2020-05-12 | -0.61 | -0.61 |
Q4 2019 | 2020-03-16 | -0.35 | -0.46 |
Q3 2019 | 2019-11-12 | -0.37 | -0.37 |
Q2 2019 | 2019-08-09 | -0.57 | -0.35 |
Q1 2019 | 2019-06-12 | -1.61 | -0.22 |
Q4 2018 | 2019-05-09 | 0.00 | -0.13 |
Q1 2018 | 0000-00-00 | Future report Set alerts |
In CRTX 67 funds of 2195 total. Show all
Fund name | Ticker shares |
---|---|
Capital Research Global Investors | 2.61M |
Capital World Investors | 2.61M |
Capital International Investors | 2.56M |
SC US (TTGP), LTD. | 1.04M |
BlackRock Inc. | 0.96M |
Vanguard Group, Inc | 0.70M |
CITADEL ADVISORS LLC | 0.30M |
STATE STREET CORP | 0.29M |
GEODE CAPITAL MANAGEMENT, LLC | 0.24M |
PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 0.23M |
NORTHERN TRUST CORP | 0.18M |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.11M |
SCHWAB CHARLES INVESTMENT MANAGEMENT INC | 92042 |
Bank of New York Mellon Corp | 76744 |
Nuveen Asset Management, LLC | 69912 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
Lutz Steven Michael Executive Vice President | 0.98% (262348) | CRTX / |
Powell Andrew Kenneth William EVP, General Counsel | 0.33% (89785) | CRTX / ITMN / MDVN / |
Morgus Vincent T. EVP, Finance and CFO | 0.18% (49644) | CRTX / |
Chiesi Farmaceutici SpA | 0.04% (10000) | CRTX / |